Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Dictionary » Neonatal olivopontocerebellar (OPCA) atrophy
 

Neonatal olivopontocerebellar (OPCA) atrophy

Neonatal olivopontocerebellar (OPCA) atrophy: Related Topics

These medical condition or symptom topics may be relevant to medical information for Neonatal olivopontocerebellar (OPCA) atrophy:

Neonatal olivopontocerebellar (OPCA) atrophy: Rare Disease

Office of Rare Diseases (ORD) of the National Institutes of Health (NIH)

Neonatal olivopontocerebellar (OPCA) atrophy is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Neonatal olivopontocerebellar (OPCA) atrophy, or a subtype of Neonatal olivopontocerebellar (OPCA) atrophy, affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)

Terms associated with Neonatal olivopontocerebellar (OPCA) atrophy:

Terms Similar to Neonatal olivopontocerebellar (OPCA) atrophy:

Source - NIH

Interesting Medical Articles:

Medical dictionaries:

More Medical Dictionary Topics

  • Kingella kingae
  • Kingsley
  • Kingsley splint
  • Kinic acid
  • Kinin
  • Kinin 10
  • Kinin 9
  • Kinin hypertension
  • Kininase II antagonists
  • Kininogen
  • Kininogen deficiency
  • Kininogen, High-Molecular-Weight
  • Kininogen, Low-Molecular-Weight

    Find out more

    Search to find out more about Neonatal olivopontocerebellar (OPCA) atrophy:

      
      
    powered by
    Google
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise